Maternal pertussis vaccination programme
From 1 July 2024, ADACEL(Tdap), a non-IPV-containing vaccine, will replace Boostrix-IPV (dTaP/IPV) for the pertussis vaccination in pregnancy programme. The Joint Committee on Vaccination and Immunisation recognises the importance of vaccinating pregnant women to protect their babies from pertussis and the advice is that Boostrix-IPV vaccine should still be given if ADACEL is not available to avoid delays in vaccination. This letter provides information to practices, commissioners and other healthcare professionals.